Kolexia
Richard-Devantoy Stephane
Psychiatrie
CHU Angers
Angers, France
112 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Démence Maladie d'Alzheimer Nausée Cicatrice Alcoolisme Fatigue Hallucinations Intoxication alcoolique Manifestations neurocomportementales

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Psychometric proprieties of the French Version of the Family-Focused Mental Health Practice Questionnaire (FFMHPQ)
European review of applied psychology = Revue europeenne de psychologie appliquee   01 mai 2024
Music as an Intervention to Improve the Hemodynamic Response of Ketamine in Depression: A Randomized Clinical Trial.
JAMA network open   05 février 2024
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.
Frontiers in psychiatry   19 septembre 2023
Ketamine Versus Electroconvulsive Therapy in Depression: Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Essai Clinique (University of Ottawa)   29 août 2023
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology   02 août 2023
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings.
Frontiers in human neuroscience   18 juillet 2023
A Study of Psilocybin for Major Depressive Disorder (MDD): A Randomized, Double-Blind, Support-of-Concept Phase 2 Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)
Essai Clinique (The Emmes Company, LLC)   31 mai 2023
Blood Biomarkers in Major Depression
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   20 avril 2023
Association between childhood cognitive skills & adult suicidal behavior: A systematic review and meta-analysis.
Journal of affective disorders   30 décembre 2022
Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression: Music as a Potential Intervention to Improve Hemodynamic Tolerability of Repetitive Sub-Anesthetic IV Ketamine Infusions in Bipolar and Unipolar Depression: A Pilot Study
Essai Clinique (Douglas Mental Health University Institute)   03 octobre 2022